| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5845601 | Pulmonary Pharmacology & Therapeutics | 2015 | 8 Pages |
Abstract
These results confirm and extend the reported highly efficient anti-mycobacterial activity of this lipophilic oxidazole derivative when it is carried by liposomes in mice suffering from late progressive pulmonary TB induced by drug-sensitive, and most prominently by, MDR strains.
Keywords
FDAXDRPBSMDRCFUCHOLINHMICH&El-α-phosphatidylcholinestandard deviationisoniazidExtensively drug-resistantTuberculosisMinimal inhibitory concentrationWorld Health OrganizationAnti-tuberculosisAnti-TBLiposomesLipophilicMycobacterium tuberculosisphosphate-buffered saline solutionMultidrug-resistantHematoxylin and Eosincolony-forming unitshuman immunodeficiency virusHIVcholesterolWHO
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Dulce Mata-Espinosa, Gloria MarÃa Molina-Salinas, Jorge Barrios-Payán, Gabriel Navarrete-Vázquez, Brenda Marquina, Octavio Ramos-Espinosa, Estela Isabel Bini, Isabel Baeza, Rogelio Hernández-Pando,